| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0 | 0.985 | Nicotinic alpha3beta2 receptor antagonist | 0.976 0.001 CID_20642901 | ||
| 0.768 | 0.002 | 0.768 | Acetylcholine nicotinic antagonist | 0.714 0.003 CID_20642901 | ||
| 0.743 | 0.002 | 0.743 | Neuronal nicotinic receptor antagonist | 0.645 0.003 CID_20642901 | ||
| 0.717 | 0.002 | 0.717 | TRPA1 agonist | 0.655 0.003 CID_20642901 | ||
| 0.678 | 0.003 | 0.678 | Acetylcholine antagonist | 0.651 0.004 CID_20642901 | ||
| 0.677 | 0.003 | 0.677 | Cholinergic antagonist | 0.655 0.004 CID_20642901 | ||
| 0.566 | 0.002 | 0.566 | Nicotinic receptor alpha3 subunit antagonist | 0.369 0.003 CID_20642901 | ||
| 0.548 | 0.008 | 0.624 | Psychostimulant | 0.624 0.005 CID_20642901 | CID_20642901 | |
| 0.565 | 0.057 | 0.565 | Apoptosis agonist | 0.562 0.058 CID_20642901 | ||
| 0.546 | 0.038 | 0.546 | Analgesic | 0.518 0.044 CID_20642901 | ||
| 0.455 | 0.007 | 0.455 | Cholinergic | 0.386 0.01 CID_20642901 | ||
| 0.449 | 0.008 | 0.449 | Alpha adrenoreceptor antagonist | 0.334 0.013 CID_20642901 | ||
| 0.476 | 0.038 | 0.488 | Calcium channel L-type activator | 0.488 0.032 CID_20642901 | CID_20642901 | |
| 0.45 | 0.041 | 0.45 | Vasodilator, peripheral | 0.387 0.059 CID_20642901 | ||
| 0.442 | 0.038 | 0.442 | 5 Hydroxytryptamine release stimulant | 0.44 0.038 CID_20642901 | ||
| 0.434 | 0.054 | 0.434 | Antiobesity | 0.434 0.054 CID_20642901 | ||
| 0.344 | 0.004 | 0.344 | Acetylcholine M4 receptor antagonist | 0.191 0.006 CID_20642901 | ||
| 0.369 | 0.038 | 0.369 | Calcium channel activator | 0.315 0.078 CID_20642901 | ||
| 0.346 | 0.031 | 0.346 | Sigma receptor agonist | 0.317 0.036 CID_20642901 | ||
| 0.295 | 0.003 | 0.295 | Antineoplastic alkaloid | 0.292 0.003 CID_20642901 | ||
| 0.289 | 0.016 | 0.289 | Acetylcholine M1 receptor antagonist | 0.259 0.023 CID_20642901 | ||
| 0.251 | 0.007 | 0.251 | Opioid kappa receptor antagonist | 0.23 0.008 CID_20642901 | ||
| 0.248 | 0.005 | 0.248 | Dopamine uptake inhibitor | 0.164 0.009 CID_20642901 | ||
| 0.221 | 0.004 | 0.221 | Nicotinic alpha4beta2 receptor antagonist | 0.179 0.005 CID_20642901 | ||
| 0.253 | 0.04 | 0.253 | P-glycoprotein inhibitor | 0.247 0.042 CID_20642901 | ||
| 0.249 | 0.07 | 0.249 | Vasodilator | 0.245 0.072 CID_20642901 | ||
| 0.201 | 0.024 | 0.201 | Antiadrenergic | 0.153 0.035 CID_20642901 | ||
| 0.196 | 0.019 | 0.196 | Alpha 2c adrenoreceptor antagonist | 0.115 0.053 CID_20642901 | ||
| 0.196 | 0.024 | 0.196 | Adrenaline antagonist | 0.147 0.035 CID_20642901 | ||
| 0.182 | 0.013 | 0.182 | 5 Hydroxytryptamine uptake inhibitor | 0.104 0.025 CID_20642901 | ||
| 0.193 | 0.026 | 0.193 | Acetylcholine muscarinic antagonist | 0.167 0.035 CID_20642901 | ||
| 0.199 | 0.033 | 0.199 | Acetylcholinesterase inhibitor | 0.17 0.044 CID_20642901 | ||
| 0.191 | 0.028 | 0.191 | 5 Hydroxytryptamine 2B antagonist | 0.124 0.057 CID_20642901 | ||
| 0.183 | 0.024 | 0.191 | MAP3K9 inhibitor | 0.191 0.019 CID_20642901 | CID_20642901 | |
| 0.171 | 0.02 | 0.171 | Opioid antagonist | 0.162 0.022 CID_20642901 | ||
| 0.211 | 0.078 | 0.215 | Antimitotic | 0.215 0.076 CID_20642901 | CID_20642901 | |
| 0.158 | 0.034 | 0.192 | Microtubule formation inhibitor | 0.192 0.022 CID_20642901 | CID_20642901 | |
| 0.171 | 0.048 | 0.171 | Tubulin antagonist | 0.162 0.053 CID_20642901 | ||
| 0.163 | 0.049 | 0.163 | Neurotrophic factor | 0.142 0.066 CID_20642901 | ||
| 0.152 | 0.038 | 0.152 | Alpha 2b adrenoreceptor antagonist | |||
| 0.138 | 0.026 | 0.138 | Acetylcholine M3 receptor agonist | 0.112 0.039 CID_20642901 | ||
| 0.117 | 0.009 | 0.117 | Dopamine transporter inhibitor | 0.088 0.015 CID_20642901 | ||
| 0.177 | 0.073 | 0.189 | Lipocortins synthesis antagonist | 0.189 0.064 CID_20642901 | CID_20642901 | |
| 0.119 | 0.019 | 0.121 | Glycine receptor antagonist | 0.121 0.018 CID_20642901 | CID_20642901 | |
| 0.102 | 0.008 | 0.102 | Nicotinic receptor alpha4 subunit antagonist | 0.087 0.011 CID_20642901 | ||
| 0.124 | 0.035 | 0.124 | Acetylcholine agonist | |||
| 0.206 | 0.125 | 0.222 | Tyrosine 3 hydroxylase inhibitor | 0.222 0.101 CID_20642901 | CID_20642901 | |
| 0.097 | 0.018 | 0.097 | TRPA1 antagonist | 0.057 0.048 CID_20642901 | ||
| 0.143 | 0.065 | 0.143 | Calcium channel blocker | |||
| 0.098 | 0.03 | 0.098 | Opioid delta receptor antagonist | 0.086 0.034 CID_20642901 | ||
| 0.088 | 0.021 | 0.088 | Acetylcholine M5 receptor antagonist | 0.063 0.038 CID_20642901 | ||
| 0.088 | 0.023 | 0.088 | Adrenaline uptake inhibitor | 0.068 0.037 CID_20642901 | ||
| 0.096 | 0.033 | 0.096 | Opioid mu receptor antagonist | 0.09 0.036 CID_20642901 | ||
| 0.099 | 0.037 | 0.099 | Alpha 2a adrenoreceptor antagonist | 0.067 0.062 CID_20642901 | ||
| 0.116 | 0.055 | 0.116 | Acetylcholine release stimulant | |||
| 0.101 | 0.047 | 0.101 | Alpha 2 adrenoreceptor antagonist | |||
| 0.062 | 0.011 | 0.083 | TRPM8 blocker | 0.083 0.008 CID_20642901 | CID_20642901 | |
| 0.09 | 0.039 | 0.09 | Alpha 1b adrenoreceptor antagonist | |||
| 0.191 | 0.141 | 0.191 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.081 | 0.032 | 0.081 | Dopamine D1 antagonist | 0.078 0.034 CID_20642901 | ||
| 0.077 | 0.031 | 0.077 | Acetylcholine M2 receptor antagonist | 0.055 0.049 CID_20642901 | ||
| 0.202 | 0.16 | 0.202 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.196 0.176 CID_20642901 | ||
| 0.08 | 0.039 | 0.08 | Calcium channel L-type blocker | |||
| 0.08 | 0.045 | 0.08 | Alpha 1a adrenoreceptor antagonist | |||
| 0.06 | 0.029 | 0.06 | Acetylcholine M2 receptor agonist | 0.052 0.039 CID_20642901 | ||
| 0.06 | 0.029 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | 0.058 0.03 CID_20642901 | ||
| 0.072 | 0.046 | 0.072 | 5 Hydroxytryptamine agonist | |||
| 0.13 | 0.106 | 0.13 | GABA C receptor rho-2 antagonist | 0.126 0.113 CID_20642901 | ||
| 0.063 | 0.04 | 0.064 | Prolactin release inhibitor | 0.064 0.036 CID_20642901 | CID_20642901 | |
| 0.061 | 0.039 | 0.061 | Potassium channel (Ca-activated) blocker | 0.056 0.051 CID_20642901 | ||
| 0.032 | 0.014 | 0.032 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.059 | 0.043 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.072 | 0.057 | 0.072 | Alpha 1 adrenoreceptor antagonist | |||
| 0.043 | 0.029 | 0.054 | Guanylate cyclase inhibitor | 0.054 0.017 CID_20642901 | CID_20642901 | |
| 0.043 | 0.03 | 0.043 | Opioid kappa receptor agonist | 0.041 0.032 CID_20642901 | ||
| 0.091 | 0.079 | 0.091 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.047 | 0.036 | 0.047 | Sigma receptor antagonist | |||
| 0.049 | 0.04 | 0.049 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.054 | 0.045 | 0.054 | Alpha 1d adrenoreceptor antagonist | |||
| 0.016 | 0.011 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.062 | 0.06 | 0.062 | Cannabinoid receptor antagonist | |||
| 0.039 | 0.038 | 0.039 | 5 Hydroxytryptamine 2C agonist | |||
| 0.082 | 0.081 | 0.082 | Butyrylcholinesterase inhibitor | |||
| 0.056 | 0.059 | 0.058 | Heme oxygenase stimulant | 0.058 0.051 CID_20642901 | CID_20642901 | |
| 0.029 | 0.04 | 0.033 | Kinesin antagonist | 0.033 0.031 CID_20642901 | CID_20642901 | |
| 0.029 | 0.04 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.031 CID_20642901 | CID_20642901 | |
| 0.051 | 0.065 | 0.054 | Lipocortins synthesis agonist | 0.054 0.05 CID_20642901 | CID_20642901 | |
| 0.068 | 0.084 | 0.09 | NMDA receptor antagonist | 0.09 0.054 CID_20642901 | CID_20642901 | |
| 0.121 | 0.197 | 0.16 | Spasmolytic | 0.16 0.155 CID_20642901 | CID_20642901 | |
| 0.059 | 0.141 | 0.078 | MAP kinase kinase 7 inhibitor | 0.078 0.053 CID_20642901 | CID_20642901 | |
| 0.155 | 0.259 | 0.224 | Sodium/bile acid cotransporter inhibitor | 0.224 0.157 CID_20642901 | CID_20642901 | |
| 0.17 | 0.372 | 0.287 | Caspase 9 stimulant | 0.287 0.208 CID_20642901 | CID_20642901 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |